ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,187.67
0.00%
US Tech 100
17,586.00
-0.15%
다우존스 지수
39,056.39
0.44%
Bitcoin
61,047.07
-2.07%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Titan Pharmaceuticals Inc (TTNP)

  7. Titan Pharmaceuticals Inc (TTNP) 뉴스

TTNP

Titan Pharmaceuticals (TTNP)

Titan Pharmaceuticals Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:TTNP
일자시간출처헤드라인심볼기업
2024/01/2606:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
2024/01/2606:29GlobeNewswire Inc.Titan Pharmaceuticals Fully Compliant With NASDAQ Listing CriteriaNASDAQ:TTNPTitan Pharmaceuticals Inc
2024/01/1906:59Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
2024/01/0907:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/12/2906:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/12/2906:15GlobeNewswire Inc.Titan Pharmaceuticals Announces Reverse Stock Split and RatioNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/11/2906:47Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/11/1806:03Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/11/1606:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/10/2705:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/10/2705:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/10/2705:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/10/2705:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/10/2705:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/10/2506:26Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/10/2404:07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/10/1706:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/10/1705:37GlobeNewswire Inc.Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of DirectorsNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/10/0506:30Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/10/0505:40Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/09/2005:41Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:TTNPTitan Pharmaceuticals Inc
2023/09/1905:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/09/1820:30GlobeNewswire Inc.Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred StockNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/09/0906:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/08/3105:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/08/1506:08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TTNPTitan Pharmaceuticals Inc
2023/08/0109:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
2023/08/0108:45Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:TTNPTitan Pharmaceuticals Inc
2023/08/0108:44Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:TTNPTitan Pharmaceuticals Inc
2023/08/0108:42Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:TTNPTitan Pharmaceuticals Inc
 검색 관련기사 보기:NASDAQ:TTNP

최근 히스토리

SPI
SP500
S&P 500
USOTC
BNPQY
BNP Paribas (QX)
COIN
SOLUSD
Solana
USOTC
BASFY
BASF (QX)
NYSE
MRK
Merck
USOTC
RHHBY
Roche (QX)
AMEX
XLE
Energy Select Sector SPDR
PM
XAUUSD
Gold vs US Dollar
NASDAQ
NVDA
NVIDIA
NASDAQ
QQQ
Invesco QQQ Trust Series 1
FX
USDJPY
US Dollar vs Yen
CCOM
US500
US 500
NYSE
NKE
Nike
CCOM
US30
US 30
NYSE
AXP
American Express
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유